Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2016

Open Access 01-12-2016 | Protocol

Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review

Authors: Christopher Plishka, Thomas Rotter, Leigh Kinsman, Mohammed Rashaad Hansia, Adegboyega Lawal, Donna Goodridge, Erika Penz, Darcy D. Marciniuk

Published in: Systematic Reviews | Issue 1/2016

Login to get access

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a respiratory syndrome characterized by progressive, partially reversible airway obstruction and lung hyperinflation. COPD has a substantial burden which is seen in both patient quality of life and healthcare costs. One proposed method of minimizing this burden is the implementation of clinical pathways (CPWs). CPWs aim to guide evidence-based practice and improve the interaction between health services. They bring the best available evidence to a range of healthcare professionals by adapting evidence-based clinical guidelines to a local context and detailing the essential steps in the assessment and care of patients.

Methods

The aim of this systematic review is to synthesize existing literature on the effects of CPWs for the treatment or management of COPD. We will screen search hits from search strategies developed for a Cochrane Effective Practice and Organisation of Care (EPOC) systematic review on the use of CPWs in primary care and a Cochrane EPOC review on the use of CPWs in hospitals. These searches were run in a range of databases. Studies will be screened independently by two reviewers. All studies identified by our search strategy will be considered regardless of study design as long as they meet the operational definition for clinical pathways developed by Kinsman et al. (BMC Medicine 8, 2010) and focus on the treatment or management of COPD. All included studies will be evaluated for risk of bias utilizing methodologies set out by the Cochrane collaboration. Data regarding patient, professional and systems outcomes will be extracted from all included studies. Data will be presented in both narrative and tabular form.

Discussion

The systematic review outlined in this protocol aims to identify, assess and synthesise all available evidence on the effects of CPWs regarding the treatment and management of COPD. As a result, this review will provide an evidence base for decision makers regarding the practicality, cost effectiveness, patient benefit and best practices regarding the implementation of CPWs for the care of COPD.
Appendix
Available only for authorised users
Literature
1.
O’Donnell DE, Hernandez P, Rocker G, Kaplan A, Aaron S, Voduc N, Bourbeau J, Marciniuk D, Balter M, Ford G, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008;15:1A.PubMedPubMedCentral
2.
3.
Mannino DM. COPD: epidemiology, prevalence, morbidity and morality, and disease heterogeneity.(chronic obstructive pulmonary disease). Chest. 2002;121(5):121S.CrossRefPubMed
4.
5.
6.
European Respiratory Society. European lung white book. Huddersfield: European Respiratory Society Journals, Ltd.; 2003.
7.
8.
9.
Centers for Disease Control and Prevention, National Center for Health Statistics. National hospital discharge survey raw data, 1999-2010: analysis performed by the American Lung Association Research and Health Education Division using SPSS software. Atlanta: Centers for Disease Control and Prevention; 2010.
10.
Schulman, Ronca, and Bucuvalas Inc (SRBI). Confronting COPD in America 2000. Silver Spring, MD: Funded by GlaxoSmithKline plc; 2000.
11.
Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–21.CrossRefPubMed
12.
13.
Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, et al. Prevention of acute exacerbation of COPD: American college of chest physicians and Canadian thoracic society guideline.(chronic obstructive lung disease)(Report). Chest. 2015;147(4):883.CrossRefPubMed
14.
Grimshaw JM, Schünemann HJ, Burgers J, Cruz AA, Heffner J, Metersky M, Cook D. Disseminating and implementing guidelines: article 13 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. In., vol. 9; 2012: 298-303.
15.
Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O’Donnell D, Maltais F, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18(2):69–78.CrossRefPubMedPubMedCentral
16.
Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, SchLinemann H, Wedzicha W, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179.CrossRefPubMed
17.
Marciniuk DD, Brooks D, Butcher S, Debigare R, Dechman G, Ford G, Pepin V, Reid D, Sheel A, Stickland M, et al. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease—practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J. 2010;17(4):159–68.CrossRefPubMedPubMedCentral
18.
19.
Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings.(Getting Research Findings into Practice, part 7). Br Med J. 1998;317(7156):465.CrossRef
20.
Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’Brien MA. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39(8 Suppl 2):II2.PubMed
21.
Grimshaw JM, Thomas RE, Maclennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii.CrossRefPubMed
22.
Grimshaw J, Eccles M, Tetroe J. Implementing clinical guidelines: current evidence and future implications. J Contin Educ Health Prof. 2004;24(Suppl 1):S31-7.
23.
McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, Decristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635.CrossRefPubMed
24.
Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001;39(8):II46–54.PubMed
25.
Westfall JM, Mold J, Fagnan L. Practice-based research—“blue highways” on the NIH roadmap. JAMA. 2007;297(4):403.CrossRefPubMed
26.
Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. Br Med J. 1998;316(7125):133.CrossRef
27.
Kinsman L, Rotter T, James E, Snow P, Willis J. What is a clinical pathway? Development of a definition to inform the debate. BMC Medicine. 2010;8:31.
28.
Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane database of systematic reviews (Online). 2010;3:CD006632.
29.
Rotter T, Kinsman L, Machotta A, Zhao F, van der Weijden T, Ronellenfitsch U, Scott SD. Clinical pathways for primary care: effects on professional practice, patient outcomes, and costs. Cochrane Database Syst Rev. 2013;8. Art. No. CD010706. DOI:10.​1002/​14651858.​CD010706.
30.
Cunningham S, Logan C, Lockerbie L, Dunn MJG, McMurray A, Prescott RJ. Effect of an integrated care pathway on acute asthma/wheeze in children attending hospital: cluster randomized trial. J Pediatr. 2008;152(3):315–20. e312.CrossRefPubMed
31.
Rotter T, Kugler J, Koch R, Gothe H, Twork S, van Oostrum J, Steyerberg E. A systematic review and meta-analysis of the effects of clinical pathways on length of stay, hospital costs and patient outcomes. In: BMC Health Serv Res. vol. 8; 2008.
32.
Schrijvers G, van Hoorn A, Huiskes N. The care pathway: concepts and theories: an introduction. International Journal of Integrated Care. 2012;12(Spec Ed Integrated Care Pathways):e192.
33.
Lodewijckx C, Sermeus W, Panella M, Deneckere S, Leigheb F, Decramer M, Vanhaecht K. Impact of care pathways for in-hospital management of COPD exacerbation: a systematic review. Int J Nurs Stud. 2011;48(11):1445–56.CrossRefPubMed
34.
Lawal AK, T. R, Kinsman L, Machotta A, Ronellenfitsch U, Scott S, Goodridge D, Plishka C, Groot G. What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review. 2016.
35.
36.
37.
38.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65.CrossRefPubMed
39.
Shemilt I, Morciano M, Thomas J. A web-based tool for adjusting costs to a specific target currency and price year. Evidence and Policy. 2010;6(1):51–9.CrossRef
40.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264.CrossRefPubMed
Metadata
Title
Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review
Authors
Christopher Plishka
Thomas Rotter
Leigh Kinsman
Mohammed Rashaad Hansia
Adegboyega Lawal
Donna Goodridge
Erika Penz
Darcy D. Marciniuk
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2016
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-016-0311-8

Other articles of this Issue 1/2016

Systematic Reviews 1/2016 Go to the issue

Protocol

Health service provider education and/or training in infant male circumcision to improve short- and long-term morbidity outcomes: protocol for systematic review

Protocol

Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis

Commentary

Time to consider sharing data extracted from trials included in systematic reviews

Methodology

Rayyan—a web and mobile app for systematic reviews

Protocol

Alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients: a systematic review protocol

Protocol

Carotid artery stenting versus no stenting assisting thrombectomy for acute ischaemic stroke: protocol for a systematic review of randomised clinical trials with meta-analyses and trial sequential analyses